Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sampson MR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ, McLaughlin, Sarah A, Wright, Mary J, Morris, Katherine T, Giron, Gladys L, Sampson, Michelle R, Brockway, Julia P, Hurley, Karen E, Riedel, Elyn R, Van Zee, Kimberly J
Publikováno v:
Journal of Clinical Oncology; 11/10/2008, Vol. 26 Issue 32, p5213-5219, 7p
Autor:
McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ, McLaughlin, Sarah A, Wright, Mary J, Morris, Katherine T, Sampson, Michelle R, Brockway, Julia P, Hurley, Karen E, Riedel, Elyn R, Van Zee, Kimberly J
Publikováno v:
Journal of Clinical Oncology; 11/10/2008, Vol. 26 Issue 32, p5220-5226, 7p
Autor:
Sampson MR; Division of Clinical Pharmacology 4, Office of Clinical Pharmacology, Office of Translational Sciences Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Troy SB, Belew Y, Arya V, Struble KA
Publikováno v:
Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2020 Jan; Vol. 15 (1), pp. 61-65.
Autor:
Hodowanec AC; Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products, Food and Drug Administration, Silver Spring, MD, USA., Pikis A; Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products, Food and Drug Administration, Silver Spring, MD, USA., Komatsu TE; Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products, Food and Drug Administration, Silver Spring, MD, USA., Sampson MR; Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Clinical Pharmacology IV, Food and Drug Administration, Silver Spring, MD, USA., Younis IR; Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Clinical Pharmacology IV, Food and Drug Administration, Silver Spring, MD, USA., O'Rear JJ; Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products, Food and Drug Administration, Silver Spring, MD, USA., Singer ME; Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products, Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2019 Jun; Vol. 59 (6), pp. 784-798. Date of Electronic Publication: 2018 Dec 26.
Autor:
Boyd SD; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products., Sampson MR; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Clinical Pharmacology IV, Silver Spring, Maryland, USA., Viswanathan P; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products., Struble KA; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products., Arya V; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Clinical Pharmacology IV, Silver Spring, Maryland, USA., Sherwat AI; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products.
Publikováno v:
AIDS (London, England) [AIDS] 2019 May 01; Vol. 33 (6), pp. 1089-1093.
Autor:
Sampson MR; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Review, Food and Drug Administration, Silver Spring, MD, USA., Cao KY; Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Gish PL; Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Hyon K; Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Mishra P; Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Tauber W; Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Zhao P; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Review, Food and Drug Administration, Silver Spring, MD, USA., Zhou EH; Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Younis IR; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Review, Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2019 Apr; Vol. 59 (4), pp. 500-509. Date of Electronic Publication: 2018 Nov 19.
Autor:
Hill KD; 1Department of Pediatrics,Duke University Medical Center,Durham,North Carolina,United States of America., Sampson MR; 2The Duke Clinical Research Institute,Durham,North Carolina,United States of America., Li JS; 2The Duke Clinical Research Institute,Durham,North Carolina,United States of America., Tunks RD; 1Department of Pediatrics,Duke University Medical Center,Durham,North Carolina,United States of America., Schulman SR; 4Department of Anesthesiology,Duke University Medical Center,Durham,North Carolina,United States of America., Cohen-Wolkowiez M; 2The Duke Clinical Research Institute,Durham,North Carolina,United States of America.
Publikováno v:
Cardiology in the young [Cardiol Young] 2016 Feb; Vol. 26 (2), pp. 354-62. Date of Electronic Publication: 2015 Apr 01.
Autor:
Sampson MR; Duke Clinical Research Institute, Durham; †Department of Pharmacotherapy and Experiment Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; ‡Department of Pediatrics, Stanford University, Palo Alto, CA; §Department of Pediatrics, Duke University Medical Center, Durham, NC; ¶Schools of Medicine and Pharmacy, University of California San Diego, La Jolla; and ‖Department of Pediatrics, University of California, San Francisco., Frymoyer A, Rattray B, Cotten CM, Smith PB, Capparelli E, Bonifacio SL, Cohen-Wolkowiez M
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2014 Oct; Vol. 36 (5), pp. 584-9.
Autor:
Sampson MR; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA., Dumitrescu TP; 1] Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA [2] Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline, Research Triangle Park, North Carolina, USA., Brouwer KL; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA., Schmith VD; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2014 Mar 05; Vol. 3, pp. e103. Date of Electronic Publication: 2014 Mar 05.